Ticker
LGVNCompany Name
LONGEVERON INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 11.27M | $ 3.28M | $ 7.99M |
3/31/2025 | $ 15.28M | $ 2.72M | $ 12.55M |
12/31/2024 | $ 19.62M | $ 2.58M | $ 17.04M |
9/30/2024 | $ 23.77M | $ 3.1M | $ 20.67M |
6/30/2024 | $ 13.41M | $ 3.21M | $ 10.2M |
3/31/2024 | $ 3.76M | $ 5.29M | $ -1.54M |
12/31/2023 | $ 5.85M | $ 3.89M | $ 1.96M |
9/30/2023 | $ 5.04M | $ 3.39M | $ 1.65M |
6/30/2023 | $ 10.29M | $ 4.08M | $ 6.21M |
3/31/2023 | $ 14.87M | $ 3.6M | $ 11.28M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for LONGEVERON INC is calculated as follows: AssetsC [ $ 2.37M ] - LiabilitesC [ $ 2.49M ]
(=) Working Capital [ $ -115.78K ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -468.61M |
max | $ 607.04M |
average | $ 96.1M |
median | $ 32.21M |
std | $ 174.5M |